ALKS

ALKERMES PLC

Healthcare | Mid Cap

$0.38

EPS Forecast

$395.4

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-03-31
NKTRNektar TherapeuticsBMRNBiomarin Pharmaceutical IncIONSIonis Pharmaceuticals IncRAREUltragenyx Pharmaceutical IncSRPTSarepta Therapeutics IncALNYAlnylam Pharmaceuticals IncJAZZJazz Pharmaceuticals PlcPAHCPhibro Animal Health Corp